EswarKrishnanMD

PubMed

• 191 citations
  A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a ra...
  Philip J. Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage
  Annals of the Rheumatic Diseases. 2020-01-01
• 140 citations
  Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Con...
  Atul Deodhar, Denis Poddubnyy, César Pacheco-Tena, Carlo Salvarani, Eric Lespessailles
  Arthritis & Rheumatology. 2019-04-01
• 28 citations
  An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
  Stanley Cohen, José L. Pablos, Karel Pavelka, Gerard Anton Müller, Alan Matsumoto
  Arthritis Research & Therapy. 2019-03-29

Journal Articles

• Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis  
  Sokolove J, Sharpe O, Brennan M, Lahey LJ, Kao AH, Krishnan E,Wasko MC, Robinson WH, Arthritis Rheum, 7/1/2013
• Upper Extremity and Mobility Subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS®) Adult Physical Functioning Item Bank  
  Hays RD, Spritzer KL, Amtmann D, Lai JS, Dewitt EM, Rothrock N, Dewalt DA, Riley WT, Fries JF, Krishnan E, Arch Phys Med Rehabil, 6/7/2013
• Serum Urate and Incidence of Kidney Disease Among Veterans with Gout  
  Krishnan E, Akhras KS, Sharma H, Marynchenko M, Wu E, Tawk RH, Liu J, Shi L, J Rheumatol, 5/15/2013
• Tophaceous gout and high level of hyperuricemia are both associated to increased risk of mortality in patients with gout  
  Perez-Ruiz F, Carmona, L Herrero-Beites AM, Pijoan JI, Krishnan E, Ann Rheum Dis, 1/12/2013
• Nature vs Nurture in gout  
  Krishnan E, Lessov-Schlaggar C, Krasnow, R, Swan, G, Am J Med, 1/1/2012
• Low level lead exposure and the risk for gout: Results from the NHANES study  
  Krishnan E, Lingala B, Bhalla V, Ann Internal Med, 1/1/2012
• Hyperuricemia in young adults and the risk for insulin resistance, prediabetes and diabetes: a 15 year follow up study  
  Krishnan E, Pandya B, Chung L, Hariri A, Dabbous O, Am J Epid, 1/1/2012
• Dutch translation and cross-cultural adaptation of the PROMIS® physical function item bank and cognitive pre-test in Dutch arthritis patients  
  Oude Voshaar MAH, ten Klooster PM, Taal E, Krishnan E, van de Laar MAFJ, Arthritis Res Ther, 1/1/2012
• Pegloticase and the patient with treatment failure gout  
  Dave A, Kelly V, Krishnan E, Expert Rev Clin Pharmacol, 1/1/2012
• Hyperuricemia and carotid artery dilatation among young adults without metabolic syndrome  
  Krishnan E, Wildman R, Cooper J, Sutton-Tyrrell K, Rheumatology Reports, 1/1/2012
• Reduced glomerular filtration and the prevalence of gout: NHANES 2009-10  
  Krishnan E, PLoS One, 1/1/2012
• Chronic kidney disease in gout in a managed care setting  
  Fuldeore MJ, Riedel AA, Zarotsky V, Pandya BJ, Dabbous O, Krishnan E, BMC Nephrol, 1/1/2011
• Disability in rheumatoid arthritis in the era of biological treatments  
  Krishnan E, Lingala B, Bruce B, Fries JF, Ann Rheum Dis, 1/1/2011
• Febuxostat for the treatment of hyperuricemia in patients with gout  
  Kelly V, Krishnan E, Int J Clin Rheumatology, 1/1/2011
• The Future of Measuring Patient-Reported Outcomes in Rheumatology  
  Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD, Arthrit Care Res, 1/1/2011
• Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study  
  Krishnan E, Pandya BJ, Chung L, Dabbous O, Arthritis Res Ther, 1/1/2011
• An Analysis of connective Tissue Disease-associated Interstitial Lung Disease at a US Tertiary Care Center: Better Survival in Patients with Systemic Sclerosis  
  Su R, Bennett M, Jacobs S, Hunter T, Bailey C, Krishnan E, Rosen G, Chung L, J Rheumatol, 1/1/2011
• Inflammation, oxidative stress and lipids: the risk triad of atherosclerosis in gout  
  Krishnan E, Rheumatology (Oxford), 1/1/2010
• Items, Instruments, Crosswalks, and PROMIS  
  Fries JF, Krishnan E, Bruce B, Journal of Rheumatology, 1/1/2009
• What constitutes progress in assessing patient outcomes?  
  Fries JF, Krishnan E, Journal of Clinical Epidemiology, 1/1/2009
• Cost and Risk of Gout Flares among the Elderly: Does Serum Uric Acid Level Matter?  
  Wu E, Patel P, Yu A, Mody R, Cahill K, Tang J, Krishnan E, J Rheumatol, 1/1/2009
• Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients  
  Schmajuk G, Bush TM, Burkham J, Krishnan E, Chung L, Clin Exp Rheumatol, 1/1/2009
• A brief report of gout in ambulatory care settings in the United States  
  Krishnan E, Lienesch D, Kwoh CK, J Rheumatol, 1/1/2008
• Hyperuricemia: Where rheumatologist meets nephrologist  
  Avram Z, Krishnan E, Rheumatology (Oxford), 1/1/2008
• Progress in assessing disability in arthritis patients: Computerized adaptive testing (CAT)  
  Fries JF, Bruce B, Rose M, Krishnan E, Arthritis and Rheumatism, 1/1/2008
• Join now to see all

Books/Book Chapters

• Oxidative Stress in Advanced Basic Research and Clinical Practice. Studies on Arthritis and Joint Diseases. 
  Chapter: Metabolic syndrome and gout. 
  Page 237 - 250Krishnan EEditors: Alcaraz M.Springer2012
• Gout & Other Crystal Arthropathies. 
  Chapter: Epidemiology and Risk factors. 
  Page 72 - 84Krishnan EEditors: Terkeltaub R.Elsevier Saunders2011
• Rheumatic Disease Clinics of North America 
  Chapter: Musculoskeletal disorders and the national health and nutrition examination surveys (NHANES). 
  Page 869 - 878Sokka T, Krishnan EEditors: Choi HK.2004
• Targeted Therapies in Rheumatology 
  Chapter: Long-term observational studies. 
  Page 667 - 677Krishnan E, Singh G, Tugwell PEditors: Smolen J, Lipsky P.Martin Dunitz, London2003
• Shaw’s Textbook of Gynaecology 
  Chapter: Epidemiology of Gynecological cancers. 
  Day NE, Krishnan EEditors: Soutter.Churchill Livingstone, Edinburgh, Scotland1997
• Join now to see all

Abstracts/Posters

• Citrullination within the Atherosclerotic Plaque: A New Potential Target for Anti-Citrullinated Protein Antibodies.
  Sokolove J, Share O, Brennan M, Krishnan et al., Arthritis and Rheumatism, 1/1/2012
• Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis.
  Reiter K, Goldhaber-Fiebert J, Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records.
  Narang N, Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Menopause and the Prevalence of Gout and Hyperuricemia: An Age-Matched Case Control Study.
  Krishnan E, Bennett M, Arthritis and Rheumatism, 1/1/2012
• Glomerular Filtration Rate, Chronic Kidney Disease and Incidence of Physician Diagnosed Gout.
  Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Prevalence of Gout Among Adults with Chronic Kidney Disease in the United States, 2009-10.
  Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Prevalence of Knee Pain in Ultramarathon Runners.
  Kelly VM, Hoffman M, Lingala B, Bennett M, Krishnan E, Arthritis and Rheumatism, 1/1/2012
• Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis.
  Dave AJ, Lingala B, Fiorentino D, Krishnan E, Chung L, Arthritis and Rheumatism, 1/1/2012
• Uncontrolled Serum Uric Acid In Veteran Gout Patients Is Associated with a Higher Risk of Diabetes.
  Pandya BJ, Marynchenko M, Sharma H, et al., Arthritis and Rheumatism, 1/1/2011
• A Patient Reported Frailty Index That Can Predict Mortality Outcomes Among Patients with Arthritis.
  Krishnan E, Fries JF, Lingala B, Arthritis and Rheumatism, 1/1/2011
• Febuxostat vs Allopurinol in Elderly Gout Subjects: Subgroup Analysis of the CONFIRMS Trial.
  Krishnan E, MacDonald PA, Hunt BJ, Jackson RL, Journal of the American Geriatrics Society, 1/1/2011
• Uncontrolled Serum Uric Acid Is Associated with An Increased Risk of Developing Renal Disease In Veterans with Gout.
  Krishnan E, Sharma H, Pandya BJ, et al., Arthritis and Rheumatism, 1/1/2011
• International Classification of Diseases-Clinical Modification-9 Codes for the Diagnosis of Dermatomyositis and Polymyositis in Discharge Summaries: Evidence of Accept...
  Narang N, Fiorentino D, Krishnan E, Chung L, Arthritis and Rheumatism, 1/1/2011
• Efficacy and Safety of Lesinurad (RDEA594), A Novel Uricosuric Agent, Given In Combination with Allopurinol in Allopurinol-Refractory Gout Patients: Preliminary Result...
  Sundy J, Perez-Ruiz F, Krishnan E, et al., Arthritis and Rheumatism, 1/1/2011
• Hyperuricemia and the Risk for Type 2 Diabetes Mellitus and Prediabetes.
  Pandya BJ, Dabbous O, Bron M, et al., Diabetes, 1/1/2010
• Health service costs and resource utilization among managed care enrollees with gout and renal disease.
  Riedel AA, Fuldeore MJ, Braun BB, Krishnan E, Value in Health, 1/1/2008
• Hyperuricemia and the risk of isolated hypertension among young people without cardiovascular and metabolic risk factors: The CARDIA study.
  Krishnan E, Choi HK, Kuller LH, Liu K, Circulation, 1/1/2007
• Treatment cost of gout in an elderly population: A claims database analysis.
  Wu EQ, Patel PA, Krishnan E, et al., Journal of the American Geriatrics Society, 1/1/2007
• Outcomes after acute myocardial infarction in systemic lupus erythematosus as compared to diabetes mellitus.
  Shah AM, Shah MA, Krishnan E, Journal of the American College of Cardiology, 1/1/2007
• Men with gout die from acute myocardial infarction at a rate higher than expected from their traditional cardiovascular risk profile.
  Krishnan E, Svendsen K, Neaton J, Grandits G, Kuller L, Annals of the Rheumatic Diseases, 1/1/2007
• Hyperuricemia and the risk for incident hypertension among middle-aged men.
  Krishnan E, Kwoh K, Schumacher R, Kuller L, Circulation, 1/1/2007
• Hospital post-CABG mortality in patients with systemic lupus erythematosus and rheumatoid arthritis.
  Kao AH, Krishnan E, Annals of the Rheumatic Diseases, 1/1/2007
• Tighter control of serum uric acid in gout is associated with lower morbidity and health care costs.
  Wu EQ, Mody RR, Krishnan E, et al., Arthritis and Rheumatism, 1/1/2006
• Verification of ICD-CM-9 coding for the diagnosis of systemic sclerosis.
  Khurma V, Furst DE, Krishnan E, Khanna D, Arthritis and Rheumatism, 1/1/2006
• Gout among veterans in the United States: 1998-2004.
  Kent Kwoh C, Skanderson M, Krishnan E, Chen L, Schumacher R, Arthritis and Rheumatism, 1/1/2006
• Join now to see all

Lectures

• Hyperuricemia and Atherothrombotic Vascular Disease-What to Do With the Evidence? 
  Washington, DC - 1/1/2012
• Uncontrolled serum uric acid is associated with an increased risk of developing renal disease in veterans with gout. 
  1/1/2011
• An item-response theory-based approach for measuring frailty in large populations. 
  Taipei, ROC - 1/1/2011
• Towards high throughput health outcome measurement. 
  Monterey, CA - 1/1/2011
• Hyperuricemia and the Risk for Type 2 Diabetes Mellitus and Prediabetes. 
  Orlando, FL - 1/1/2010
• Progress in health outcome measurement: The PROMIS project. 
  Kansas City, KS - 1/1/2010
• Interventions for hyperuricemia sans gout: What when why and how. 
  London, UK - 1/1/2010
• Reducing sample size needs in clinical trials. 
  Borneo, Malaysia - 1/1/2010
• Hyperuricemia and the risk of isolated hypertension among young people without cardiovascular and metabolic risk factors: The CARDIA study. 
  Orlando, FL - 1/1/2007
• Tighter control of serum uric acid in gout is associated with lower morbidity and health care costs. 
  1/1/2006
• Time trends in cumulative disability in Rheumatoid Arthritis 1960-1998. 
  1/1/2001
• Join now to see all